[HTML][HTML] Phenylalanine hydroxylase deficiency

JJ Mitchell, YJ Trakadis, CR Scriver - Genetics in medicine, 2011 - Elsevier
Phenylalanine hydroxylase deficiency is an autosomal recessive disorder that results in
intolerance to the dietary intake of the essential amino acid phenylalanine. It occurs in …

Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis

SE Waisbren, K Noel, K Fahrbach, C Cella… - Molecular genetics and …, 2007 - Elsevier
Blood phenylalanine (Phe) levels provide a practical and reliable method for the diagnosis
and monitoring of metabolic status in patients with phenylketonuria (PKU). To assess the …

National institutes of health consensus development conference statement: phenylketonuria: screening and management, October 16–18, 2000

… Institutes of Health Consensus Development Panel - …, 2001 - publications.aap.org
Objective. To provide health care providers, patients, and the general public with a
responsible assessment of currently available data regarding screening for and …

Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III …

HL Levy, A Milanowski, A Chakrapani, M Cleary, P Lee… - The Lancet, 2007 - thelancet.com
Background Early and strict dietary management of phenylketonuria is the only option to
prevent mental retardation. We aimed to test the efficacy of sapropterin, a synthetic form of …

Nutritional management of phenylketonuria

EL MacLeod, DM Ney - Annales Nestlé (English ed.), 2010 - karger.com
Phenylketonuria (PKU) is caused by deficient activity of the enzyme phenylalanine
hydroxylase, needed to convert the essential amino acid (AA) phenylalanine (phe) to …

Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo …

FK Trefz, BK Burton, N Longo, MMP Casanova… - The Journal of …, 2009 - Elsevier
OBJECTIVE: To evaluate the ability of sapropterin dihydrochloride (pharmaceutical
preparation of tetrahydrobiopterin) to increase phenylalanine (Phe) tolerance while …

Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino acid–based medical foods for nutrition …

SC Van Calcar, DM Ney - Journal of the Academy of Nutrition and Dietetics, 2012 - Elsevier
Phenylketonuria (PKU), an inborn error in phenylalanine metabolism, requires lifelong
nutrition management with a low-phenylalanine diet, which includes a phenylalanine-free …

Dietary management practices in phenylketonuria across European centres

K Ahring, A Bélanger-Quintana, K Dokoupil, HG Ozel… - Clinical nutrition, 2009 - Elsevier
BACKGROUND: Dietary phenylalanine restriction is the cornerstone of phenylketonuria
(PKU) management. However, there are no European consensus guidelines for its optimal …

Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations

SCJ Huijbregts, LMJ De Sonneville, R Licht… - Neuropsychologia, 2002 - Elsevier
Fifty-seven 7–14-year-old early-and continuously treated phenylketonuria (PKU) patients
and 65 matched controls performed a sustained attention task. PKU patients with plasma …

Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: a meta-analysis

J Albrecht, SF Garbade, P Burgard - Neuroscience & Biobehavioral …, 2009 - Elsevier
Although pathogenesis of phenylketonuria is not completely understood, a low
phenylalanine diet is effective to prevent severe neurological impairment, mental retardation …